This study also aimed to evaluate PCAT-1 and FENDR as prognostic indicators for predicting the recurrence of thyroid cancer and to test their ability to discriminate between PTCs and benign thyroid tumors. The gene discussed is PCAT1; the disease is thyroid gland carcinoma.